Expression of HLA-DR antigen in early squamous cell lung cancers (English)
National licence
- New search for: Yazawa, T.
- New search for: Kamma, H.
- New search for: Ogata, T.
- New search for: Yazawa, T.
- New search for: Kamma, H.
- New search for: Ogata, T.
In:
Lung Cancer
;
7
;
39
;
1991
-
ISSN:
- Article (Journal) / Electronic Resource
-
Title:Expression of HLA-DR antigen in early squamous cell lung cancers
-
Contributors:
-
Published in:Lung Cancer ; 7 ; 39
-
Publisher:
-
Publication date:1991-01-01
-
Size:1 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Source:
Table of contents – Volume 7
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Relationship between smoking and lung cancer cell typeDu, Y.X. / Cha, Q. / Chen, Y.Z. et al. | 1991
- 1
-
Dose response relationships for asbestos and lung cancer| 1991
- 1
-
IntroductionVan Houtte, P. et al. | 1991
- 2
-
Analysis of the relationship between lung cancer cell type and some associated factorsLei, Y.X. / Du, Y.X. / Chen, Y.Z. et al. | 1991
- 2
-
Atmospheric pollution and human lung cancerDu, Y.X. / Feng, J.W. / Chen, Y.Z. / Wu, J.M. et al. | 1991
- 2
-
Lung cancer cases analysis in the annual of pathological autopsy cases in Japan (1958–1989)| 1991
- 2
-
A comparative study of lung cancer in black and white patientsSmith, C / Feldman, C / Zwi, S / Kallenbach, JM et al. | 1991
- 3
-
The risk factors for lung cancer in womenXu-Dong, Dai / Xi-Wen, Son / Su-Fen, Yu et al. | 1991
- 3
-
Prognostic factors in non-small cell lung cancer: a consensus reportFeld, Ronald / Arriagada, Rodrigo / Ball, David L. / Mattson, Karin / S∅rensen, Jens Benn et al. | 1991
- 3
-
Five year results of new lung cancer screening programme using mass miniature radiograph| 1991
- 3
-
Lung cancer at a young age in New Zealand| 1991
- 3
-
A review of lung cancer in the atomic bomb survivors — Treated cases at Nagasaki Atomic Bomb Hospital from 1983–1990| 1991
- 4
-
Histological sub-type of lung cancer is subject to age and sex specific differences| 1991
- 4
-
Incidence of lung cancer (LC) in middle-aged Japanese company employees| 1991
- 4
-
Carcinogenesis studies of the extract of Aspergillus versicolor culture on the human fetal lung tissue in vitro| 1991
- 4
-
Mycotoxins and Lung Cancer| 1991
- 5
-
Lung cancer among married couplesMäkipaja, K et al. | 1991
- 5
-
The lung cancer registration project in Flanders (Belgium): An interim analysis of the first 1000 casesVan Meerbeeck, J. / Weyler, J. / Uydebrouck, M. / Deneffe, G. / Joos, G. / Van de Maele, B. / Van den Eeckhout, A. et al. | 1991
- 5
-
Risk and type of lung cancer and mesothelioma in patients with pleural plaquesMD,FCCP Hillerdal, Gunnar et al. | 1991
- 5
-
Lung cancer in New South WalesMcCredie, Margaret / Coates, Marylon / Taylor, Richard et al. | 1991
- 6
-
The problem of the future. The discrepancy between numbers of new cancers totally, lung cancer especially and the society as a whole in year 2010| 1991
- 6
-
Predictive value of current cigarette smoking, pack years and tar exposure in the estimation of lung cancer riskVirtamo, J / Taylor, PR / Huttunen, JK / Edwards, BK / Järvinen, P / Haapakoski, J / Hartman, A / Haukka, J / Heinonen, OP / Albanes, D et al. | 1991
- 6
-
The occupational distribution of mortality of lung cancer in Shijiazhuang| 1991
- 6
-
A case-control study on risk factors of lung cancer in no-smoking woman in rural area, China| 1991
- 7
-
Lung Cancer in young patientsOrphanidou, D. / Veslemes, M. / Tsintiris, K. / Vamvouni, C. / Vasalos, P. / Manias, A. / Chatzinicolaou, V. / Damianaki, A. / Rapakoulias, P. / Jordanoglou, J. et al. | 1991
- 7
-
Bronchogenic carcinoma in the elderly veteransChin, HW / Ampil, F / Anderson, WM / Barker, R et al. | 1991
- 7
-
Pretreatment minimal staging for non-small cell lung cancers: a consensus reportGoldstraw, P. / Bureau, G. / Cullen, M. / Dabouis, G. / Deneffe, G. / Drings, P. / Harper, P. / Lacquet, L. / Latto, G. / Pastorino, U. et al. | 1991
- 8
-
Asbestos program in FinlandMD,FCCP Huuskonen, Matti S. et al. | 1991
- 8
-
Antismoking programme addressed to women| 1991
- 9
-
Yearly courses for teachers| 1991
- 9
-
Antismoking programme addressed to military personnel| 1991
- 9
-
Antismoking programme in the school| 1991
- 9
-
Abstract part I the European action against tobaccoTubiana, Maurice et al. | 1991
- 10
-
Abstract part III the European action against tobaccoTubiana, Maurice et al. | 1991
- 10
-
Abstract part II the European action against tobaccoTubiana, Maurice et al. | 1991
- 10
-
Evaluation of smoking habit among young population for targeting anti-smoking campaign| 1991
- 10
-
Detecting lung cancer in a large cohort| 1991
- 11
-
Postoperative adjuvant treatments for non-small cell lung cancers: a consensus reportHolmes, E.C. / Bleehen, N.M. / Le Chevalier, T. / Ettinger, D. / Jett, J.R. / Johnson, D. / Komaki, R. / Saijo, N. / Sause, W. / Trovo, M. et al. | 1991
- 11
-
Characteristics of lung cancer and indoor air pollution in Xuan Wei, China| 1991
- 11
-
ATBC lung cancer prevention study| 1991
- 11
-
The process and impact of a hospital becoming smoke-freeMcCall, CB / Carr, DT / Eriksen, MP et al. | 1991
- 11
-
A randomized chemoprevention trial in stage I lung cancer with high-dose retinol palmitatePastorino, U. / Infante, M. / Maioli, M / Chiesa, G. / Clerici, M. / Soresi, E. / Valente, M. / Belloni, PA / Ravasi, G. et al. | 1991
- 12
-
A study of IL-2 activity changes of lung cancer patientsXing, ZL / Wang, YZ et al. | 1991
- 12
-
Differential expression of cell adhesion molecules on lung cancer cell lines| 1991
- 13
-
The cultivation of human embryo broncho-epithelia cell (HEBE) treated with carcinogens and sex hormonesDu, Y.X. / Gao, H.G. / Jin, B. / Zhan, D.J. et al. | 1991
- 13
-
Serum levels of ferritin in patients with lung cancer (LC)Ferrigno, D. / FCCP Buccheri, GF. et al. | 1991
- 13
-
Chemosensitivity of transplantable non-small cell bronchial rat tumours growing subcutaneously or in the lung| 1991
- 13
-
Metabolism of benzo(a)pyrene by human fetal lung microsomeJin, B. / Chen, J.K. / Yi, F. / Du, Y.X. et al. | 1991
- 14
-
A new monoclonal antibody against a marker for squamous cell differentiation in human lung cancervan Duijnhoven, Hans L.P. / Schalkwijk, Joost / Kranenborg, Marion H.G.C. / Sc. Wagenaar, Sjoend / Springall, David R. / Polak, Julia M. / Wim, J.M.van de Ven et al. | 1991
- 14
-
Characterization of the L-MYC promoter: Promoter activity and DNA: Protein binding sites| 1991
- 14
-
Chemiluminescence responses of alveolar macrophages obtained from each lung in patients with lung cancerHosker, HSR / Page, RL / Muers, MF et al. | 1991
- 14
-
Autocrine motility factor-like substance (AMF) in human lung cancer cell lines| 1991
- 15
-
Induction therapy for NSCLC: a consensus reportKlastersky, Jean / Burkes, Ronald / Choi, Noah / Dombernowsky, Per / Darwish, Samir / Ginsberg, Robert J. / Gregor, Anna / Ihde, Daniel C. / Kocha, Walter / MacBeth, Fergus et al. | 1991
- 15
-
Blood neutrophil and monocyte function following chemotherapy in patients with small cell lung cancerHosker, HSR / Scott, Y / Kesteven, P / Corris, PA et al. | 1991
- 15
-
A new differentiation marker for small-cell lung cancer (SCLC) cell lines: a compound with γ-enolase antigen but without enzym activitySplinter, T.A.W. / Verkoelen, C. / Vlastuln, M. / v.d. Gaast, A. et al. | 1991
- 15
-
An immunohistochemical study of cellular proliferation markers in CDDP resistant and sensitive tumors in non-small cell lung cancer| 1991
- 15
-
Small cell lung cancer (SCLC) antigens are expressed differently on human continuous cultured cell lines representing SCLC “classic,” “variant,” and carcinoid phenotypesKoros, A.M.C. / Atchison, R.W. / Mitchell, D.L. et al. | 1991
- 16
-
An orthotopic model system for human lung cancer| 1991
- 16
-
New serum cancer-associated protein as a reliable tumor marker of lung cancer| 1991
- 16
-
Study on biological characteristics of human lung adenocarcinoma cells with different metastatic phynotypes| 1991
- 16
-
Induction of lymphokine-activated killer(LAK) activity and its regulation by blood monocytes in patients with lung cancer| 1991
- 17
-
Synergistic effects of chemotherapy and anti-epidermal growth factor receptor (EGFr) monoclonal antibodies (MAb)| 1991
- 17
-
Metastatic potential of human lung adenocarcinoma correlate with plasminogen activator production, not correlate with platelet aggregating potential and cell attachment activityAdachi, Toshiyuki / Inufusa, Haruhiko / Mori, Nobuhira / Hara, Satoshi / Tanaka, Nobuya / Nakamura, Masato / Yasutomi, Masayuki et al. | 1991
- 17
-
Inhibition of human lung cancer metastasis using antiplatelet drug and sialidase| 1991
- 17
-
Genetic changes in pre-invasive lesions of the respiratory tract| 1991
- 18
-
Lung tumour cell proliferation may be driven by multiple bombesin-related peptides| 1991
- 18
-
Expression of multiple binding protein genes by human lung tumour cell lines| 1991
- 18
-
Establishment of doxorubicin-resistant human small-cell lung cancer cell line(SBC-3/DXR) and effect of new synthetic anthracyline analogs and antifolates| 1991
- 18
-
Effects of unilateral lung collapse on development of lung tumor in miceKawamura, Ken / Katayama, Hiroo / Takemoto, Kazuo / Matsumoto, Kunihiko et al. | 1991
- 19
-
Quality control in NSCLC treatment: a consensus reportRoemans, P. / Emami, B. / Cox, J. / Pacagnella, A. / Holsti, L. / Monteau, M. / Helle, P. / Comis, R. / Schaake, C. et al. | 1991
- 19
-
Expression of tenascin in human primary lung cancers| 1991
- 19
-
Drug-resistant small cell lung cancer (SCLC) cells are more sensitive to lonidamine (LND), a new cytotoxic agent, than the parent cells| 1991
- 19
-
Study of cell kenetics in human lung cancer and “so called” precancerous conditions in the lung and bronchiMorohoshi, T. / Shimizu, A. / Kameda, Y. / Ishibashi, M. / Nakayama, H. / Matsumoto, A. et al. | 1991
- 19
-
CDDP-resistant (SBC-3/CDDP) and VP16-resistant (SBC-3/VP16) small cell lung cancer(SCLC) cells show a unique collateral sensitivity in culture| 1991
- 20
-
In vitro induction of HLA-DR antigen expression in human lung cancer cells| 1991
- 20
-
Radiation sensitivities in various anticancer drug resistant human lung cancer cell lines and mechanism of radioresistance in cis-diamminedichloroplatinum (II) resistant lung cancer cell line| 1991
- 20
-
Basic fetoprotein (BFP) in primary lung cancerFujita, Yukihisa / Goto, Takechika / Fujii, Tsuneo / Hiramori, Norihiro / Kida, Takao / Arimoto, Taichiro / Nakagaki, Yoshinobu / Sakai, Mayuka / Iwasaki, Yoshinobu / Nishiyama, Katsuhiko et al. | 1991
- 20
-
Inhibitory effects of β-carotene on proliferation in vitro and metastasis in vivo of lung cancer cellsLai, BT / Wang, H / Liu, GZ / Jiao, FH / Yan, H et al. | 1991
- 21
-
Pretreatment minimal stagingGoldstraw, Peter et al. | 1991
- 21
-
Frequency of point mutational activation of the K oncogene in non-small cell lung cancer in Hong Kong| 1991
- 21
-
Sensitivity to etoposide (VP16) and expression of DNA-topoisomerase II (TII) in small cell lung cancer cell lines| 1991
- 21
-
Specific cytolytic T cell clones for an autologous small cell lung cancer (SCLC) cell line| 1991
- 21
-
Competent and priming activities affecting GRP and IGF-I in proliferation of small cell lung cancer cell lines| 1991
- 22
-
Different energy metabolism in two small cell lung cancer (SCLC) subpopulations examined by 31P-magnetic resonance spectroscopy (MRS) and biochemical analysis in vivo and in vitro| 1991
- 22
-
Selective reactivity of CIBr monoclonal antibodies (MAb) with lung carcinoma cells| 1991
- 22
-
Nuclear A-type lamins are differentially expressed in lung cancer subtypes| 1991
- 22
-
Sensitivity to adriamycin of two sets of small cell lung cancer (SCLC) cell lines from individual patients| 1991
- 23
-
“Tumor pairs” established from the same patient as a model for investigation of drug resistance in human small cell lung cancer| 1991
- 23
-
Expression of adhesion molecules of the cadherin family and of NCAM in small cell lung cancer cell lines and xenografts| 1991
- 23
-
Growth kinetics of small cell lung cancer (SCLC) xenografts grown in nude miceSpang-Thomsen, Mogens / Rygaard, Kåre et al. | 1991
- 23
-
Differential radiosensitivity of small cell lung cancer (SCLC) cell lines determined by two complementary in vitro assays| 1991
- 24
-
Receptors for transforming growth factor β and epidermal growth factor in small cell lung cancer cell lines| 1991
- 24
-
Refractory small cell lung cancer (SCLC) and myc family oncogenes| 1991
- 24
-
Susceptibility of a human small cell lung cancer (SCLC) cell line to autologous peripheral lymphocytes and induction of tumor-specific killer cells| 1991
- 24
-
Expression of myc family onco-proteins in small cell lung cancer cell lines and xenograftsRygaard, Kåre / Spang-Thomsen, Mogens et al. | 1991
- 25
-
Characterization of ectopic production of atrial natriuretic factor (ANF) in a small cell lung cancer cell line and tumor| 1991
- 25
-
Nuclear DNA content analysis using bronchoscopic brushing specimens of non-small cell lung carcinoma| 1991
- 25
-
Examination of oncogene mRNA in primary lung adenocarcinoma by in situ hybridizationKawamata, Osamu / Inoue, Fumiyuki / Kamikawa, Yasuaki / Funaki, Naoto / Moriki, Yasuyuki / Muramatsu, Tomoyoshi / Hayashi, Doufu / Okabayashi, Takahiro / Horimi, Tadashi / Orita, Kunzo et al. | 1991
- 25
-
Fluorescence properties of lung cancer cell and normal lung cells using LASER and hematoporphyrin derivative| 1991
- 26
-
Gene analysis of pulmonary lymphoproliferative disorders| 1991
- 26
-
Expression of the multidrug resistence related mdr-1 gene in human lung and untreated lung cancer| 1991
- 26
-
Effect of topoisomerase II levels on comparative chemosensitivity of lung cancer cell lines| 1991
- 26
-
Effect of IL-2, IL-6, and IL-8 transfection on the rejection of Lewis lung carcinoma| 1991
- 27
-
Production of immunoreactive ProGRP(31-98) in small cell lung carcinomaMiyake, Y. / Nagasaki, K. / Otsubo, K. / Urakami, K. / Saigenji, K. / Yamaguchi, K. et al. | 1991
- 27
-
The expression of growth factors and the corresponding receptors in human non-small cell lung cancer cell lines. Factors of potential importance for auto and paracrine growth regulation| 1991
- 27
-
In vitro and In vivo effects of [D-Arg1,D-Phe5,D-Trp7,9,Leu11] substance P (D-Phe5SP) on the growth of human lung cancer cell lines and xenografts| 1991
- 27
-
Growth inhibition of neuroendocrine lung cancer cell lines via inhibition of peptidyl α-amidation enzyme(s)| 1991
- 27
-
Prognostic factors in patients with non-small cell lung cancer. A critique of the world literatureMaki, E. / Feld, R. et al. | 1991
- 28
-
Production of tumor necrosis factor alpha (TNF-α) in lung cancer patients| 1991
- 28
-
Secretary type and intracellular type of thiol protease inhibitors purified from human lung cancer cell lineYoshioka, S. / Kuranishi, F. / Nishiki, M. / Dohi, K. et al. | 1991
- 28
-
Screening of point mutations on p53 gene in tissues from primary lung cancer using single-strand conformation polymorphisms analysisMatsuda, Kunihiro / Takahashi, Hideki / Seyama, Kuniaki / Ohwada, Akihiko / Nukiwa, Toshihiro / Kira, Shiro et al. | 1991
- 28
-
Effect of immunomodulator on neutrophils migration to pulmonary alveoli and on alveolar macrophage functions in lung metastasis model| 1991
- 29
-
The association between histological type, neuroendocrine differentiation and drug sensitivity of lung cancer cell lines| 1991
- 29
-
Anti-proliferative effect of glucocorticoids and anti-glucocorticoids on non-small cell lung cancer in vitroBeattie, C.W. / Bratescu, L. / Thomas, P.A. et al. | 1991
- 29
-
Glucocorticoid receptors in squamous lung cancer cell cytosolsThomas, P.A. / Graves, J. / Han, M.C. / Beattie, C.W. et al. | 1991
- 29
-
Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer?| 1991
- 30
-
Nude mice with lacZ transduced human tumor xenografts as an in vivo model for invasion and metastasisSpang-Thomsen, Mogens / Zwiebel, James A. / Rygaard, Jørgen / Brünner, Nils et al. | 1991
- 30
-
Analysis of chromosome abnormalities in pleural effusions from patients with non-small cell lung cancer (NSCLC)| 1991
- 30
-
Large scale automated sequencing of oncogenes in resectable lung tumours| 1991
- 30
-
Topoisomerase gene expression in normal and neoplastic human lung| 1991
- 31
-
Implication of the β receptor of retinoic acid in epidermoid lung cancer| 1991
- 31
-
Variation in the immune system in patient with polmonary carcinomas| 1991
- 31
-
Measurement of cell proliferation in NSCLL cell lines using K167, PCNA and BrdU labelling| 1991
- 31
-
Cellular composition of human primary non-small cell lung carcinomas analyzed by immunophenotype and morphology. Purification of tumour cells by flow cytometry| 1991
- 32
-
Immunohistochemical localization of parathyroid hormone-related protein in bronchial carcinoma| 1991
- 32
-
Role of proteolytic system in lung metastases development at experimental tumors in mice| 1991
- 32
-
Dynamic proliferation assessment of lung cancer with in vivo BrdU labeling and bivariate DNA flowcytometryten Velde, G. / Tinnemans, M. / Lenders, M. / Schutte, B. / Blijham, G. et al. | 1991
- 32
-
A McAb LC-1 which against human lung cancerGe, X.R. / Wang, J. / Lin, S.J. / Che, Y.F. / Li, M. et al. | 1991
- 33
-
Specific chromosome regions involved nonrandomly in cytogenetic abnormalities in primary non-small cell lung cancer (NSCLC)| 1991
- 33
-
Expression of glutathione S-transferase π gene in human lung cancer cell lines| 1991
- 33
-
Value of cytological assessment in determining ability to obtain a karyotype in non-small cell lung cancer (NSCLC)| 1991
- 33
-
Co-amplification of parathyroid hormone-related protein (PTHrP) and C-KI-RAS-2 in a human lung cancer cell line| 1991
- 34
-
The micronucleus assay in the study of the radiosensitivity of human lung cancer cell lines| 1991
- 35
-
Light and electron microscopic correlation study of pulmonary sclerosing hemangiomas| 1991
- 35
-
Limits and perspectives of surgical resection for non-small cell lung cancerGinsberg, R.J. et al. | 1991
- 35
-
TNF-binding sites and TNF in human lung cancerKayser, K / Gabius, H-J / Hagemeyer, O et al. | 1991
- 36
-
Biomarkers participate in the interrelationship and dynamic spectrum of lung cancer| 1991
- 36
-
Profiling of free plasma amino acids in lung cancer patientsZhang, Pingchang / Chen, Yongzhong et al. | 1991
- 36
-
Small cell carcinoma of lung. Sex and survival| 1991
- 36
-
The frequency of lung cancer - an autopsy based study| 1991
- 37
-
819 primary lung carcinoma cases hospitalized in medical faculty of Ankara University between 1981–1989| 1991
- 37
-
Reproducibility of histopathological evaluation in adenocarcinoma of the lungSørensen, J.B. / Hirsch, F.R. / Gazdar, A. / Olsen, J.E. et al. | 1991
- 37
-
The possibility of clinical application on lung cancer by McAb Lc-1 against human lung cancer through fiberobronscopy biopsy| 1991
- 37
-
Basement membranes (BM) in adenocarcinomas of the lung: an immunohistochemical (IH) and electron-microscopical (EM) studyten Velde, G. / Thunnissen, F. / Dingemans, K. / Wagenaar, S. / Tiebosch, T. / Bosman, F. et al. | 1991
- 38
-
Pathological analysis of Japanese lung cancer in the agedSato, T. / Ito, Y. / Miyaishi, O. / Tauchi, H. / Yamamoto, T. et al. | 1991
- 38
-
Clinical significance of p53 tumor suppressor gene abnormalities in lung cancer| 1991
- 38
-
Familial non small cell bronchogenic carcinoma (NSCLC): A clinic-pathological study of four siblings| 1991
- 38
-
Detection of SLX in carcinoma of the lung| 1991
- 39
-
Expression of HLA-DR antigen in early squamous cell lung cancersYazawa, T. / Kamma, H. / Ogata, T. et al. | 1991
- 39
-
Expression of HLA-DR antigen in lung cancers and its correlation to histologic types and lymphocytic infiltration| 1991
- 39
-
Leucocyte elastase in lung adenocarcinoma tissueOhshika, Y. / Ozeki, Y. / Kase, K. / Takagi, K. / Kikuchi, K. / Tanaka, S. / Mamiya, G. / Ogata, T. et al. | 1991
- 39
-
Immunohistochemical study of ADF/hTx expression in associated lymphoid tissue of lung cancer| 1991
- 40
-
A quantitative study of the frequency of (preneoplastic changes) dysplasia of the respiratory tract in association with non small cell lung cancer| 1991
- 40
-
Pulmonary adenocarcinoma cells DNA content quantitative analysis in effusion| 1991
- 40
-
Image cytometric DNA analysis in smear specimens of non-small cell lung cancer| 1991
- 40
-
Diagnostic sensitivity and prognostic implications of immunreactive NCAM in small cell lung cancer| 1991
- 41
-
Immunohistochemical and cytofluorometric analyses of atypical adenomatous hyperplasia of the lungNakayama, H. / Noguchi, M. / Shimosato, Y. / Matsumoto, A. et al. | 1991
- 41
-
A morphometric analysis of individual cell death in bronchial carcinoids| 1991
- 41
-
Late BCNU lung: A light and ultrastructural study on the delayed effect of BCNU on the lung parenchyma| 1991
- 41
-
Primary malignant fibrous histiocytoma of the lung| 1991
- 41
-
Limits and perspectives of irradiation in locally advanced non-small cell lung cancer (NSCLC)Gregor, Anna et al. | 1991
- 42
-
Thymic squamous cell carcinoma with secretion of PTH-rP from hepatometastatic tumor and hypercalcemiaMiyake, Maki / Horiuchi, Noriaki / Fujino, Osamu / Oka, Koichi / Ono, Kazuo / Hizawa, Kazuo et al. | 1991
- 42
-
Squamous-cell lung carcinoma in a case of juvenile-onset papillomatosis: Detection of HPV DNA type 11 in benign, metaplastic and malignant lesions by the Polymerase Chain Reaction (PCR)| 1991
- 42
-
Detection of Human Papillomavirus (HPV) type 16 DNA in squamous--cell carcinoma and adenocarcinoma of the lung using the Polymerase Chain Reaction (PCR)Gaweco, A. / Eberlein-Gonska, M. / Becker, H. / Neimeier, A. / Drings, P. / Otto, H.F. et al. | 1991
- 42
-
Diagnostic value of CEA and TPA in exudative pleural effusionsDe Angelis, G. / Alma, M.G. / Bigioni, D. / Pallotta, G. / Munno, R. / Pigorini, F.C. et al. | 1991
- 43
-
Is DNA image cytometry of sputum specimens a valuable tool for the early detection of lung cancer? Preliminary report of bronchial brushings and aspirates DNA measurementsAssailly, J. / Baldeyrou, P. / Brugal, G. et al. | 1991
- 43
-
Histologic typing of lung cancer in association with exposure to asbestos| 1991
- 43
-
Percutaneous biopsy of parenchymal lung lesions using a biopty gunAllen, CM / Hansell, DH / Sheppard, MN et al. | 1991
- 43
-
Monoclonal antibodies (mabs) for detection of metastatic carcinoma cells in bone marrow of Small Cell Lung Cancer (SCLC)Skov, B.G. / Bobrow, L. / Hirsch, F.R. / England, London. et al. | 1991
- 44
-
Neuroendocrine differentiation in Non-Small Cell Lung Cancer (NSCLC) (preliminary results)| 1991
- 44
-
Vascular invasion in non small cell lung cancer| 1991
- 45
-
Prognostic significance of mediastinal node level invasion in non small cell lung cancerConill, C / Astudillo, J / Verger, E / Teixidor, J / Solé, J / Serrano, M / Barberá, J / Aguilera, J / Rosell, R et al. | 1991
- 45
-
Prognostic indicators in lung cancer patients complicated with pleural effusionsShi-Chuan, Chang / Reury-Perng, Perng et al. | 1991
- 46
-
Immunohistochemical analysis of P-glycoprotein 170 in non-small cell lung cancer| 1991
- 46
-
Multivariate survival analysis of 360 patients with Squamous Cell Lung Cancer (SCLC)FCCP Buccheri, GF. / Ferrigno, D. / Vola, F. / Rosso, A. et al. | 1991
- 46
-
Long-term survival and prognostic assessment of resected neuroendocrine lung cancer at early stageLequagtle, C. / Cataldo, I. / Preda, F. / Ravasi, G. et al. | 1991
- 46
-
Anti-CEA immunoscintigraphy versus computed tomography (CT) in lung cancer (LC) stagingBuccheri, GF / Biggi, A. / Ferrigno, D. / Leone, A. / D'Angeli, B. / Quaranta, M. / Taviani, M. / Comino, A. et al. | 1991
- 47
-
Nuclear DNA and nuclear protein content in cases with lung adenocarcinomaMD,FCCP Gönüllü, U. / MD Numanoǧlu, N. / MD Alper, D. / MD Savaş, I. / MD Özdemir, Ö. et al. | 1991
- 47
-
Detection of dysplasia and in-situ carcinoma by fluorescence imaging| 1991
- 47
-
Nutritional status as prognostic factors in lung cancer patients| 1991
- 47
-
Tissue Polipetide Antigen (TPA) has a great prognostic capability in Lung Cancer (LC)FCCP Buccheri, GF. / Ferrigno, D. et al. | 1991
- 47
-
Pre-operative radiation therapy in non-small cell cancer of the lungPayne, David G. et al. | 1991
- 48
-
An algorithm for staging patients (PTS) with Small Cell Lung Cancer (SCLC) can save more than 40% of the initial evaluation costs in both the United States and Australia| 1991
- 48
-
Super-long-term survival over 15 years of 128 postoperative patients with lung cancer| 1991
- 48
-
New aspects in the staging of lung cancer - validation of the new TNN classification (4th ed.)Drings, P. / Bülzebruck, H. / Danzer, B. / Bauer, E. / Bopp, R. / Krysa, S. / Probst, G. / Vogt-Moykopf, I. et al. | 1991
- 48
-
Cushing's syndrome associated with ectopic ACTH production and Small Cell Lung Cancer (SCLC)| 1991
- 49
-
The prognostic significance of 3 tumour markers (NSE, TPA, SACE) in patients with small cell lung cancerHosker, HSR / Day, J / Jones, GM / Tarbitt, I / Corris, PA et al. | 1991
- 49
-
Undervalued prognostic factors? The possible role of Initial tumor size (ITS) and clinical severity staging (CSS) in stage III NSCLC| 1991
- 49
-
The prognostic value of monocyte function in patients with small cell lung cancer (SCLC)Hosker, HSR / McArdle, P / Corris, PA et al. | 1991
- 49
-
The nutritional status of patients with small cell lung cancer before and during treatment with chemotherapyHosker, HSR / Jones, GM / Corris, PA et al. | 1991
- 50
-
Pericardial effusion as clinical first appearance of non-small cell lung cancer: Prognostic value and therapy| 1991
- 50
-
Prognostic significance of cellular DNA content in lung cancer| 1991
- 50
-
Serum sialic acid determination in diagnosis of lung cancer and continuous observation during clinical treatment| 1991
- 50
-
Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours| 1991
- 51
-
Adenosquamous carcinoma of the lung: Clinical characteristics and prognosisKunishima, K. / Suyama, M. / Karasawa, K. / Kuwahara, M. / Ariyoshi, Y. et al. | 1991
- 51
-
Four cases of lung cancer with metastasis to the stomachOhtsuka, Hidehiko / Yamada, Minehiko / Shimizu, Susumu / Akizawa, Takanori / Narushima, Michiaki / Tanaka, Kazumasa / Suzuki, Hajime / Noguchi, Eisei et al. | 1991
- 51
-
Locoregional staging of lung cancer by endoscopic needle aspiration biopsy| 1991
- 51
-
Cytological diagnosis and DNA content analysis in lung cancer| 1991
- 52
-
A prognostic factor risk index in advanced non-small cell lung cancer (NSCLC) treated with combination chemotherapy including cisplatinShinkai, T. / Eguchi, K. / Sasaki, Y. / Tamura, T. / Ohe, Y. / Kojima, A. / Okamoto, H. / Piantadosi, S. / Saijo, N. et al. | 1991
- 52
-
Clinical significance of flow cytometric nuclear DNA content in non-small cell lung cancer| 1991
- 52
-
Transbronchial aspiration biopsy for determination of the N-factor in lung cancerIshii, M. / Kato, H. / Konaka, C. / Kawate, N. / Yoneyama, K. / Takahashi, H. / Sakai, H. / Okunaka, T. / Miura, H. / Saito, H. et al. | 1991
- 52
-
Fine needle puncture of carina with fiber-bronchoscopeOhaly, Y / Hillerdal, G et al. | 1991
- 53
-
Primary lung cancer (PLC) — Experience with a multidisciplinary approach| 1991
- 53
-
Proposals regarding some deficiencies in the new international staging system for lung cancer| 1991
- 53
-
Prognostic factors in patients with small cell lung cancer (SCLC)| 1991
- 53
-
Differentiation and prognosis of lung cancerMukai, Masaki / Kuramishi, Fumito / Yoshioka, Shinkichiro / Nishiki, Masayuki / Dohi, Kiyohiko et al. | 1991
- 54
-
Clinicopathological study of malignant tumor of the thymus (invasive thymoma, thymic carcinoma and thymic carcinoid)| 1991
- 54
-
Cromogranin A, a possible tumor marker in small cell lung cancer| 1991
- 54
-
Gastrin-releasing peptide (GRP) and progastrin-releasing peptide (PRO-GRP) measured in the plasma of 169 patients with small cell lung cancer (SCLC)| 1991
- 54
-
Epidermal growth factor (EGF) in non-small cell lung cancer — Correlation with survivalIshikuro, Akihiko / Miyamoto, Hiroshi / Akita, Hirotoshi / Haneda, Hitoshi / Fujino, Michihiro / Katou, Masakazu / Kawakami, Yoshikazu et al. | 1991
- 55
-
Tumoral volume and prognosis in limited small-cell lung carcinoma (S.C.L.C.)Baldeyrou, P. / Bouaouina, N. / Arriagada, R. / Ruffie, P. / Le Chevalier, T. et al. | 1991
- 55
-
Natural survival of patients with lung cancer detected during cancer screening in Xuan Wei, China| 1991
- 55
-
Superior vena cava syndrome (SVCS) is a risk factor for brain metastasis in small cell lung cancer (SCLC)| 1991
- 55
-
Pre and post resection pleural cytology in patients undergoing lung resection and mediastinal node mapping for carcinoma| 1991
- 56
-
Thoracotomy staging of small cell lung cancer| 1991
- 56
-
Flow cytometric (FCM) DNA ploidy in lung cancer| 1991
- 56
-
The impact of neuroendocrine and epithelial differentiation on recurrence and survival in patients with lung cancer| 1991
- 56
-
Comparison of N status as determined by preoperative CT and by intraoperative node mapping in 150 patients undergoing resection for carcinoma of the lung| 1991
- 57
-
The signification of coagulation and fibrinolytic parameters in patients with lung cancer| 1991
- 57
-
Mediastinoscopic evaluation of stage IIIA lung cancer: defining a population for pre-operative treatment trials| 1991
- 57
-
Bone marrow (BM) metastases in patients with small cell lung cancer (SCLC) detected by morphological and immunological methods| 1991
- 57
-
Primary staging of carcinoma of the bronchus - is computer tomography of the brain necessary?| 1991
- 57
-
Postoperative radiotherapy for lung cancerVan Houtte, P. et al. | 1991
- 58
-
Prognostic factors in small cell lung cancer (SCLC). RECPAM analysis on 1,651 pts treated in Copenhagen during 1973 – 1987| 1991
- 58
-
Effect of prestudy tumor stage and of chemotherapy-radiotherapy (CT-RT) in non-small cell lung cancer (NSCLC)| 1991
- 58
-
Application of positron emission tomography in the staging of lung cancer| 1991
- 58
-
A multicentre consensus model for prognostic factors in small cell lung carcinoma (SCLC)| 1991
- 59
-
Flow cytometric heterogeneity of primary lung cancer and lymph node metastasesMD Tirindelli Danesi, D. / MD Mecozzi, A. / MD Bangrazi, C. / MD Mancini, M. / MD Modini, C. et al. | 1991
- 59
-
Pre-operative risk evaluation for lung cancer resection| 1991
- 59
-
Prognostic factors for survival in advanced non small cell lung cancer (NSCLC): The experience of the european lung cancer working party. Institut Jules Bordet-Brussels-Belgium| 1991
- 59
-
(SCLC)| 1991
- 60
-
The level of carcinoembryonic antigen, tissue proliferative antigen and carbonhydratic antigen 19.9 in serum of patients with different hystological types of lung cancerSajkov, D. / Stefanovski, T. / Ilievska-Poposka, B. / Spirovski, M. et al. | 1991
- 60
-
Neuron specific enolases: diagnostic marker for small cell lung cancerStefanovski, T. / Sajkov, D. / Ilievska-Popovska, B. / Spirovski, M. et al. | 1991
- 61
-
Pneumothorax CT for the Evaluation of Tumor Invasion of the Chest Wall and the Mediastinum in Lung Cancer| 1991
- 61
-
A study of two anti-carcinoembryonic antigen (CEA) monoclonal antibodies (Mabs) in the immunoscintigraphy of small-cell lung cancer (SCLC)Morgan, D.A.L. / Macmillan, C.H. / Perkins, A.C. / Wastie, M.L. et al. | 1991
- 62
-
In vivo somatostatin receptor imaging in lung cancerKho, G.S. / Krenning, E.P. / Lamberts, S.W.J. / Bakker, W.H. / Oei, H.Y. / Splinter, T.A.W. / Hilvering, C. / Kwekkeboom, D.I. et al. | 1991
- 62
-
Prognostic value of response to chemotherapy using ultrasound in lung cancer with metastatic liver involvementMD Goerg, Christian / MD Schwerk, W.B. / MD Wolf, M. / MD Havemann, K. et al. | 1991
- 62
-
Early detection and localization of lung cancerKato, Harubumi / Konaka, Chimori / Okunaka, Tetsuya / Hayata, Yoshihiro et al. | 1991
- 62
-
Usefulness of cine MR imaging in evaluation of cardio-vascular invasion of lung cancers or mediastinal tumors| 1991
- 63
-
Use of the MAb 3F8 in imaging small-cell lung carcinoma| 1991
- 63
-
Clinical usefulness of subtraction CT scan image for lung cancer therapyKato, S. / Asai, T. / Ohno, K. / Ohnuma, N. / Nomura, H. / Nakamoto, T. / Iizuka, M. et al. | 1991
- 63
-
Immunoscintigraphy in small cell lung cancer (SCLC): a mouse xenograft tumor study with SC-1 MoAb| 1991
- 63
-
Diagnosis of mediastinal lymph node metastasis of lung cancer with positron emission tomography using 11C-methionineMiyazawa, Hideki / Arai, Takashi / Inagaki, Keizou / Morita, Takatomo / Yano, Makoto et al. | 1991
- 64
-
Helical scan CT (HS-CT) for detection of peripheral pulmonary nodules (PPN)| 1991
- 64
-
Evaluation of dynamic - table sliding rapid sequence - thin slice computed tomography scan in diagnosis of lymph node metastasis in lung cancer| 1991
- 64
-
Transesophageal color doppler echogram for the assessments of thoracic neoplasms| 1991
- 64
-
Ultrasonographical findings of chest wall tumor in patients with primary and metastatic lung cancerSaito, Hiroyuki / Dambara, Takashi / Muramatsu, Masashi / Obata, Kenichi / Nukiwa, Toshihiro / Kira, Shiro et al. | 1991
- 65
-
Ultrasonographic approach for diagnosing chest wall invasion of primary lung cancer| 1991
- 65
-
The respective roles of radiation therapy and chemotherapy in non-small cell carcinoma of the lung with mediastinal but not distant metastasis (N2M0)Cox, James D. et al. | 1991
- 65
-
Ultrasonically guided aspiration needle biopsy for the diagnosis of cervical lymph node metastasis from lung cancer| 1991
- 65
-
Mediastinal staging of bronchial carcinoma: Accuracy of computerized tomography and mediastinoscopyKristensen, S / Aaby, C et al. | 1991
- 65
-
Ultrasonographical configuration of thoracic cavities after pleurodesis in patients with malignant pleural effusionObata, Kenichi / Dambara, Takashi / Saito, Hiroyuki / Ueki, Jun / Aiba, Miyoji / Doi, Yoshiyuki / Nukiwa, Toshihiro / Kira, Shiro et al. | 1991
- 66
-
A pathological-radiological study of the tumor-lung margin (TLM) of primary lung cancer| 1991
- 66
-
Adrenal masses in lung cancer: Sonographic diagnosis and follow-upMD Goerg, Christian / MD Schwerk, W.B. / MD Wolf, M. / MD Havemann, K. et al. | 1991
- 66
-
201T1 uptake ratio is a useful index for tumour doubling time in lung cancerTakekawa, Hironori / Yamazaki, Koichi / Watanabe, Naomi / Sukou, Noriaki / Kunikane, Hiroshi / Ogura, Shigeaki / Abe, Shosaku / Kawakami, Yoshikazu / Ito, Kazuo et al. | 1991
- 66
-
Early detection of the central endobronchial tumor by a new imaging technique| 1991
- 67
-
Secondary pulmonary lobule and small peripheral pulmonary carcinoma rentgenologic-pathologic correlative study| 1991
- 67
-
Computerized tomography (CT) for evaluation of response to therapy in small cell lung cancer (SCLC)| 1991
- 67
-
Comparison of amber and high KV chest films in the detection of lung carcinoma| 1991
- 67
-
Usefulness of the esophageal ultrasonography for detection and characterization of hilar and mediastinal lymph nodes invasion by primary lung cancerM.D. Nakajima, J. / M.D. Shindo, G. / M.D. Kubota, H. / M.D. Takeshita, M. / M.D. Furuse, A. et al. | 1991
- 68
-
The radioimmunolocalization of McAb LC-1 and its fragment in nude mice bearing lung adenocacinomaXi-rui, Ge / Shen-nian, Wang / Si-jun, Lin / Rongzeng, Cao / Ming, Li / Jin, Shen / Zhong-yi, Yao / Lingji, Chen / Su-yin, Zhang / Ji-xiao, Ma et al. | 1991
- 68
-
Bone marrow metastases in small cell lung cancer: Evaluation of magnetic resonance imagingBuhé, T. / Fiche, M. / Rogé, C. / Bizais, Y. / Lacroix, H. / Dabouis, G. et al. | 1991
- 68
-
Magnetic resonnance imaging evaluation of bone-marrow involvement in small cell lung cancer: A post- mortem confrontation with autopsic verification in six treated patientsFiche, M. / Rogé, C. / Buhé, T. / Lacroix, H. / Dabouis, G. et al. | 1991
- 68
-
Positron emission tomography for optimized therapy monitoring| 1991
- 69
-
Imaging of human SCLC with radiolabelled monoclonal antibodies against EMBP in a nude mouse model| 1991
- 70
-
Surgical treatment of lung cancer in patients over 60 years of ageChen, DI et al. | 1991
- 70
-
Pathological specialith of bronchial carcinoid and experience of diagnosis and treatmentWu, X. et al. | 1991
- 71
-
Surgical adjuvant therapy of non-small-cell lung cancerCarmack Holmes, E. et al. | 1991
- 71
-
Surgery for malignancy of trachea and main bronchus (report of 21 cases)Lin, Tao-ping / Wu, J.F. / Yang, Y.Y. / Hang, G.T. et al. | 1991
- 71
-
Diagnosis and treatment of small cell lung cancer to discuss and consider Part 2: Treatment| 1991
- 71
-
The importance of complete resection in the multimodality treatment of SCLCKarrer, K. / Shields, T. et al. | 1991
- 71
-
Postpneumonectomy space control with SF6Miura, Kazumasa / Tamaki, Hirofumi / Fukumoto, Taizo / Yoshizawa, Kiyoshi / Morita, Junji et al. | 1991
- 72
-
Postoperative studies in patients with stage III and IV lung cancerTake, A. / Yamaguchi, T. / Horimi, H. / Murayama, F. / Sohara, Y. / Fukushima, K. / Hasegawa, T. et al. | 1991
- 72
-
Surgery after chemotherapy with continuation of chemotherapy in limited, including N2, small-cell lung cancer: A prospective studyLewiński, T. / Żuławski, M. / Turski, C. / Maryniak, R. / Kozłowicz, I. / Smorczewska, M. / Pietraszek, A. / Kawecki, A. et al. | 1991
- 72
-
The management of postpneumonectomy space with sulfur hexafluorid (SF6) gas prevents deterioration of the opposite lung| 1991
- 72
-
Follow - up assessment of patients having Nd-Yag laser resection of endo-bronchial lesions| 1991
- 73
-
Surgical treatment of primary lung cancer under 40 years old| 1991
- 73
-
Extended operations for T4 primary lung cancerAyabe, H. / Tagawa, Y. / Kawahara, K. / Tomita, M. et al. | 1991
- 73
-
Operative indication of small primary lesion with advanced diseaseShimizu, Junzo / Oda, Makoto / Hayashi, Yoshinobu / Watanabe, Yoh et al. | 1991
- 73
-
Results of surgical treatment for T4 lung cancerOda, Makoto / Watanabe, Yoh / Shimizu, Junzo / Hayashi, Yoshinobu / Ohta, Yasuhiko et al. | 1991
- 74
-
The risk factor of resected pathological T 1 N 0 M 0 lung cancerDr. Tanaka, Hironori / Dr. Niwa, Hiroshi / Dr. Yamakawa, Yosuke / Prof. Masaoka, Akira et al. | 1991
- 74
-
The post-operative survival on 1055 cases of stage III lung cancer| 1991
- 74
-
Surgical therapy for apical invading lung cancer by different approaches according to tumor locationNiwa, H / Masaoka, A / Yamakawa, Y / Iizuka, M et al. | 1991
- 74
-
Surgical treatment for small sized (2cm or less in diameter) peripheral type lung cancer lesions| 1991
- 75
-
Significance of extended resection for T3 and T4 lung cancerChiba, W. / Ikeda, S. / Adachi, M. / Yamamoto, Y. / Sawai, S. / Konishi, T. / Matsubara, Y. et al. | 1991
- 75
-
Limited resection for stage I carcinoma of lung| 1991
- 75
-
Systematic bilateral mediastinal dissection and en bloc pulmonary resection through the median sternotomyHata, E. / Miyamoto, H. / Mitoma, Y. / Hayakawa, K. et al. | 1991
- 75
-
Application of the Nd-YAG laser for surgical resection of pulmonary metastases| 1991
- 76
-
Surgical treatment for advanced lung cancer with pleural dissemination| 1991
- 76
-
Radical segmentectomy for X-ray-negative squamous cell carcinoma of the bronchus| 1991
- 76
-
The evaluation of surgical treatment of primary lung cancer in the elderlyMizuno, T. / Sano, M. / Kobayashi, T. / Matsui, H. et al. | 1991
- 76
-
Simultaneous lung resection and coronary artery reconstruction in patients with lung cancer and ischemic heart diseases| 1991
- 77
-
Surgery for lung cancer invading the chest wall| 1991
- 77
-
Surgical management of stage II lung cancer| 1991
- 77
-
Sequential chemotherapy and radiotherapy for initial management of Stage IIIA and Stage IIIB non-small cell lung cancer — induction chemotherapyGreen, Mark R. et al. | 1991
- 77
-
Flap resection of lateral wall of trachea, carina, and bronchus for carina invasive lung cancerMitsui, K. / Akaogi, E. / Onizuka, M. / Morita, R. / Ishikawa, S. / Kinoshita, T. / Yamamoto, T. / Ishibashi, O. / Ogata, T. / Hori, M. et al. | 1991
- 77
-
Results of extended operation for advanced lung cancer| 1991
- 78
-
Influence of surgical resection before and after chemotherapy on survival in small cell lung cancer| 1991
- 78
-
The “kergin” pneumonectomy| 1991
- 78
-
Primary lung cancer in young adults under 40 years oldMaruyama, Shuichiro / Ando, Akio / Date, Hiroshi / Shimizu, Nobuyoshi / Teramoto, Shigeru et al. | 1991
- 78
-
Actuarial 5-yr. survival after resection of N 2 lung cancer| 1991
- 79
-
Bronchoplastic and tracheobronchoplastic procedures for lung cancer| 1991
- 79
-
Clinical apsect of early hilar lung cancerWatanabe, Y. / Shimizu, J. / Oda, M. / Hayashi, Y. / Ikegaki, S. / Takashima, T. / Kamimura, R. / Nonomura, S. et al. | 1991
- 79
-
T4 (trachea-heart-great vessels) lung cancer surgery| 1991
- 79
-
Necessity of mediastinal lymph nodes dissection in operable lung cancer (a randomized study)| 1991
- 80
-
Treatment of small cell lung cancerLi, Zejian / Ren, Hua / Zhang, Zhiyong / Sun, Chengfu / Xu, Letian / Yu, Hongquan / Li, Longyun / Zhou, Juechu / Yan, Hongzhen / Liu, Hongrui et al. | 1991
- 80
-
Closure of the bronchial stump fistula with fibrin sealentOrłowski, T.M. / Oudek, K. / Kaleta, M. et al. | 1991
- 80
-
Surgical resection for T4 tumor in non-small cell lung cancer| 1991
- 80
-
Stenting of the tracheo-bronchial treeOrłowski, Tadeusz M. et al. | 1991
- 81
-
The role of tracheobronchoplasty for extensive and limited operation against lung cancer| 1991
- 81
-
Autologous blood transfusion for operation of the lung cancerWatanabe, M. / Niwa, Y. / Kobayashi, T. / Kawamura, M. / Kato, R. / Kikuchi, K. / Kobayashi, K. / Ishihara, T. et al. | 1991
- 81
-
Palliative endobronchial laser-resection. Its role in multimodal treatment of advanced lung cancer| 1991
- 81
-
Conbined resection in lung cancer and intraoperative echogramTatsumura, T. / Kasazima, M. / Koyama, S. / Sugiyama, S. / Tsujimoto, M. / Nishide, R. / Furuno, T. / Yamamoto, K. et al. | 1991
- 82
-
Right pneumonectomy and carinal reconstruction in anterior thoracotomy for lung cancer| 1991
- 82
-
The role of limited lung resection for bronchogenic carcinomaPrakash, D. / Al-Jilaihawi, A.N. / Ogunnaike, H. et al. | 1991
- 82
-
Most peripheral, node-negative non-small cell lung cancer (NSCLC) have absence of intra- and peritumoral blood and lymphatic vessel invasion and low proliferative rates, which provides a rationale for treatment with wedge resection (WR) alone| 1991
- 82
-
Late appearance of malignancies after surgery for TI no non-small cell lung cancer| 1991
- 83
-
Feasibility of surgery after chemotherapy (CT)| 1991
- 83
-
The application of microwave therapy on cases with late thoracic malignant tumor — 16 cases reportChen Di et al. | 1991
- 83
-
Patients with T1 N0 non-SCLC lung cancerM.D. Ginsberg, Robert J. / Ph.D. Rubinstein, Lawrence et al. | 1991
- 83
-
Long-term postthoracotomy pain| 1991
- 84
-
Sleeve lobectomy for lung cancerRea, F. / Sartori, F. / Calabró, F. / Loy, M. / Erroi, L. / Bortolotti, L. / Toniolo, L. et al. | 1991
- 84
-
Thoracoscopy: Its evaluation as method of selection in the etyological diagnosis of the pleural pathologyPire, R. / Galvez, C. / Bonamassa, M.A. et al. | 1991
- 84
-
Patient controlled analgesia (PCA) in the management of thoracotomy patients| 1991
- 84
-
Pancoast's tumor: results of combined treatment (irradiation and radical resection)Rea, F. / Sartori, F. / Calabró, F. / Mazzucco, C. / Bortolotti, L. / Tomio, L. et al. | 1991
- 85
-
Limited resection for stage I lung cancerPastorino, Ugo / Valente, Maurizio / Bedini, Vittorio / Infante, Maurizio / Tavecchio, Luca / Gherardini, Giulio / M.D. Ravasi, Gianluigi et al. | 1991
- 85
-
Combined radiotherapy with chemotherapy for inoperable non-small cell lung cancerBleehen, Norman M. et al. | 1991
- 85
-
Segmentectomy, wedge resection and lobectomy for non small cell lung cancerGotti, G. / Paladini, P. / Maccherini, M. / Haid, M. / Di Bisceglie, M. / Lisi, G. / Biagi, G. et al. | 1991
- 85
-
Resectable N2 disease according to the predicted location of enlarged mediastinal nodesValente, M / Musumeci, R / Tavecchio, L / Muscolino, G / Pastorino, U / Bedini, AV / Ravasi, G et al. | 1991
- 85
-
Postoperative complications after thoracotomy for lung cancer in the elderlyFiacchi, M / Di Gaetano, P / Grazia, M / Bini, A / Bazzocchi, R et al. | 1991
- 86
-
Role of surgery for isolated cerebral metastasis in patients with resectable non-small cell lung cancer| 1991
- 86
-
Nenagnent of NSCLC at stage III. Past experienceMD Modini, C. / MD Tirindelli Danesi, D. / MD Cicconetti, F. / MD Mancini, M. / MD Necozzi, A. / MD, FACS Stipa, S. et al. | 1991
- 86
-
The survival in different N2 site infiltration in patients operated on for lung cancerGotti, G. / Paladini, P. / Maccherini, M. / Haid, M. / Di Bisceglie, M. / Miraldi, F. / Biagi, G. et al. | 1991
- 86
-
Palliative resection of massive pleural metastases from extrathoracic sarcomas — (MPMES)| 1991
- 87
-
Endobronchial chemotherapy (EBCH) in combined NSCLC treatmentCicénas, S / Aleknavičius, E / Valuckas, K et al. | 1991
- 87
-
Lung function after irradiation in patients with lung cancer and borderline lung functionsAbratt, RP / Willcox, PA / Smith, JA et al. | 1991
- 88
-
Combination of radiation and iriquinone (Iq7611) in the treatment of lung carcinomaLi, Wei-lian / Niu, Zhao-lin / Chang, Li et al. | 1991
- 88
-
The application of microwave therapy on cases with late thoracic malignant tumor — 16 cases| 1991
- 89
-
High dose conventional fractionation radiation therapy in unresectable non-small cell lung cancer: Patients with good prognostic factorsM.D. Ememi, B. / M.D. Graham, M.L. / Lockett, M.A. et al. | 1991
- 89
-
Prospective randomised trial of palliative radiotherapy (RT) given in two fractions (F2) or one fraction (F1) for patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status| 1991
- 89
-
Radiotherapeutic palliation of spinal epidural compression in small cell lung cancer| 1991
- 89
-
Postoperative radiation therapy in non-small cell lung cancerEmemi, B. / Kaiser, L. / Simpson, J. / Shapiro, S. / Roper, C. / Lockett, M.A. et al. | 1991
- 90
-
Single dose prophylactic cranial irradiation (PCI) for small cell lung cancer (SCLC)Stout, R. / Burt, P.A. / Thatcher, N. et al. | 1991
- 90
-
The impact of individual computerised treatment planning on the results in bronchogenic carcinomas| 1991
- 90
-
Brachytherapy in patients with recurrences after external irradiation: A phase II study| 1991
- 90
-
The influence of various split durations on survival in radical split-course radiotherapy in nonsmall cell lung cancer (NSCLC) patients| 1991
- 91
-
Endobronchial radiotherapy as palliation in patients with central airway malignanciesHelle, P.A. / Slingerland, R. / van der Sangen, M.J.C. / Heysteeg, M. / Levendag, P.C. / Koper, P.C.M. et al. | 1991
- 91
-
Treatment results of non-resectable lung cancer: Radiation alone versus combined radiochemotherapy| 1991
- 91
-
Assessment of late radiation damage in inoperable bronchial carcinoma patients treated by radical radiotherapy| 1991
- 91
-
Ga-67 scintigraphy for detection of recurrent lung cancer following radiotherapyNakayama, Y. / Hayakawa, K. / Mitsuhashi, N. / Tsuchiya, M. / Niibe, H. et al. | 1991
- 91
-
Response rate as criterium to evaluate chemotherapy in non-small cell lung cancerSplinter, Ted A.W. et al. | 1991
- 92
-
Elective brain irradiation (EBI) in small cell lung cancer (SCLC)| 1991
- 92
-
Fast neutron radiotherapy for non-small cell lung cancer: Results of NTCWG randomized trial 85-24Ph.D., M.D Laramore, G.E. / Ph.D. Krall, J.M. / M.D. Maor, M.H. / M.D. Griffin, T.W. / M.D. Burnison, M. / M.D. Taylor, M.E. / M.D. Davis, L.W. et al. | 1991
- 92
-
Prediction of radiotherapeutic effectiveness for inoperable primary lung cancer based on multi-variate analysis of CT criteriaEndow, M. / Suzuki, H. / Nakashima, Y. / Ishikawa, T. / Saeki, S. et al. | 1991
- 92
-
Radical radiotherapy in stage I–III epidermoid carcinoma of the lung| 1991
- 93
-
Changes of type III procollagen N-terminal peptide (P-III-P), prolylhydroxylase (PH), and laminin P1 levels after radiotherapy of lung cancer| 1991
- 93
-
The role of radiotherapy in small cell lung carcinoma (SCLC) limited disease. Experience in our departmentPetriz, L / Ballester, R. / Haddad, J. / Martinez Ferri, F. / Lozano, A. / Cambra, M.J. / Pera, J. et al. | 1991
- 93
-
Concomitant chemotherapy and radiotherapy in advanced lung cancer. A randomized studyPetriz, L. / Arellano, A. / Ballester, R. / Galiana, R. / Cambray, M. / Arnaiz, M. / Gutierrez, C. / Pera, J. et al. | 1991
- 93
-
Primary carcinoma of the tracheaDar, A.R. / Dr. Springer, C. et al. | 1991
- 94
-
Post-operative radiotherapy in non small cell lung carcinoma: Ten years of experience and definitive results| 1991
- 94
-
Radiotherapy planning of lung cancer using CT simulation systemM.D. Kusima, Takeyuki / M.D. Imanaka, Kazufumi / M.D. Kono, Michio et al. | 1991
- 94
-
Small cell lung cancer (SCLC) negative results of a randomized clinical trial on delayed thoracic radiotherapy administered to complete responders (CR) patients| 1991
- 94
-
Optimizing the role of radiotherapy in the treatment of limited stage small cell lung cancer (LSCLC)| 1991
- 95
-
The competing risk approach in determining relapse-free survival in limited small cell lung carcinoma| 1991
- 95
-
Brain metastasis in patients treated by surgery and adjuvant radiotherapy for non small cell lung carcinoma: Incidence, radiotherapy and analysis of the results| 1991
- 95
-
Intraluminal irradiation of obstructing bronchial tumours. Clinical results, survival and outcome| 1991
- 95
-
Endobronchial radiotherapy for malignant bronchial obstruction or recurrence| 1991
- 96
-
Treatment and planning decisions in non-small cell carcinoma of the lung - An Australasian patterns of practice study| 1991
- 96
-
Metastatic spinal cord compression secondary to lung cancer| 1991
- 96
-
Primary tumour volume as prognostic factor for bronchial carcinoma| 1991
- 96
-
Does postoperative irradiation affect pulmonary function in patients with Non-Small Cell Lung Cancer (NSLC)?| 1991
- 97
-
Postoperative radiotherapy for locally advanced lung cancers: Importance of mediastinal involvement on treatment outcome| 1991
- 97
-
Does preoperative RF capacitive hyperthermia combined with radiotherapy increase survival rate in advanced lung cancer?| 1991
- 97
-
High dose rate endobronchial brachytherapy using the microselectronGrafton, C. / Lam, S. / Voss, N. / Fairey, R. / Goddard, K. / Yuen, K. et al. | 1991
- 97
-
Postoperative radiotherapy after pneumectomy for lung cancers impact of modern treatment facilitiesPhlips, P. / Rocmans, P. / Vanderhoeft, P. / Van Houtte, P. et al. | 1991
- 98
-
Influence of radiotherapy (Rt) on blood histamine of patients with Non-Small Cell Lung Cancer (NSCLC)Teixeira, E. / Julio, I. / Sotto-Mayor, R. / Azevedo, M.S. / Maçanita, J. / Bugalho de Almeida, A. / Manso, C. / Freitas e Costa, M. et al. | 1991
- 98
-
Meta-analysis of randomized trials evaluating the role of thoracic radiotherapy in limited small cell lung carcinoma (SCLC)| 1991
- 98
-
Efficacy of radiotherapy in 79 patients with brain metastases from primary lung cancer| 1991
- 98
-
Long term palliation of advanced tracheobronchial tumors by HDR brachytherapy in the interdisciplinary conceptvan Bodegom, P.C. / Becker, H.D. / Fritz, P. / Schraube, P. / Drings, P. / Wannenmacher, M. / Vogt-Moykops, I. et al. | 1991
- 99
-
Prospective study confronting wide field RT versus strictly involved in the management of non-small lung cancer. An analysis of early locoregional failures and toxicityGramaglia, A. / Milani, F. / Basso Ricci, S. / Villa, S. / Bedini, A.V. / Ravasi, G. et al. | 1991
- 99
-
Longer survival with higher doses of thoracic radiotherapy in non small cell lung cancer (NSCLC)Ball, D / Matthews, J / Worotniuk, V / Crennan, E et al. | 1991
- 99
-
Surgery (S) vs surgery + radiotherapy (S+RT) in T2 - N1–2 non small cell lung carcinoma (NSCLC). An analysis of mean term data| 1991
- 99
-
Non-conventional fractionated radiotherapy in the treatment of patients with non small cell lung cancer| 1991
- 100
-
HD-DDP plus VP-16 in the treatment of advanced lung cancer — Report of 89 patientsXie Qiufang / Xiong Hui / Sun Yan / He Yan et al. | 1991
- 100
-
Laboratory research on the opening of the blood-brain barrier with veinous drip of mannitolFuyi, Xing et al. | 1991
- 101
-
Utility of the chemotherapy in advanced non small cell lung cancer (NSCLC): Results of a meta-analysisSouquet, P.J. / Boissel, J.P. / Bernard, J.P. et al. | 1991
- 101
-
Etoposide scheduling in combination chemotherapy for limited disease small cell carcinoma — A prospective studyAbratt, RP / Jansen, ER / Salton, DGM et al. | 1991
- 101
-
Combination chemotherapy and cytokines in the treatment of advanced primary lung cancer: Controlled clinical trial three year results| 1991
- 101
-
A clinical research on treatment of nonoperative lung carcinoma with multiple cerebral metastasis by chemical drugs treatmentFuyi, Xing et al. | 1991
- 102
-
Carboplatin, vinblastin and mitomycin (CMV) in advanced and disseminated non small cell lung cancer (NSCLC)Souquet, P.J. / Fournel, P. / Glot et al. | 1991
- 102
-
Efficacity of carboplatin in brain metastasis of lung cancerVelay, B. et al. | 1991
- 102
-
Single agent oral etoposide in advanced NSCLC (chronic daily) and in elderly patients with SCLCGatzemeier, U. / Neuhauss, R. / Heckmayr, M. et al. | 1991
- 102
-
Randomized trial of carboplatin (CBDCA) and etoposide (E) administered either IV in a three-day schedule or in a protracted oral mode in non-small cell lung cancer (NSCLC)| 1991
- 103
-
A phase II-trial wiht sulofenur in advanced NSCLCGatzemeier, U. / Neuhauss, R. / Drings, P. / Manegold, C. et al. | 1991
- 103
-
Prospective randomised trial of 3 or 6 courses of etoposide cyclophosphamide methotrexate and vincristine and of 6 courses of etoposide and ifosfamide in small-cell lung cancer (SCLC)| 1991
- 103
-
Lonidamine (LND) vs mitomycin/vindesine (MV) vs MV + LND in extensive stage non-small-cell lung cancer (NSCLC) — A prospective randomized phase III-TrialGatzemeier, U. / Neuhauss, R. / Koschel, G. / Kaukel, K. / Häussinger, H. / Pawel, J.v. / Cavalli, E. / Martinelli, G. et al. | 1991
- 103
-
Chemotherapy of patients with extensive stage small-cell lung cancer with carboplatin/etoposide/vincristin (CEV) vs. etoposide/vincristine (EV) a phase III trialGatzemeier, U. / Neuhauss, R. / Pawel, J.v. / Laumen, R. / Hossfeld, D.K. et al. | 1991
- 104
-
Phase II study of mitomycin C, etoposide and vindesine in stage IV non small cell lung cancer (NSCLC)| 1991
- 104
-
Adriamycin(A), cyclophosphamide(CY), nitrogen mustard(M), 5-fluorouracil(F), cis platinum(P) and lomustine(L), in non small cell lung cancer (NSCLC)| 1991
- 104
-
Carboplatin plus epirubicin plus VP-16, concurrent radiotherapy and “adjuvant” surgery for limited small cell lung cancer (SCLC)Gridelli, C. / Maiorino, A. / Curcio, C. / D'Aprile, M. / Ianniello, G. / Brancaccio, C. / Palmeri, S. / Gentile, M. / Comella, G. / Pedicini, T. et al. | 1991
- 104
-
Chemotherapy with MACC and lonidamine (LND) in unresectable NSCLC: A phase II study| 1991
- 105
-
Weekly-divided cisplatin for extensive non-small cell lung cancer| 1991
- 105
-
Phase II study of carboplatin + etoposide + epirubicin (CEE) in small cell lung cancerSantomaggio, C. / Di Vincenzo, M. / Labardi, C. / Lopes Pegna, A. / Nutini, S. / Righi, R. / Romagnoli, E. et al. | 1991
- 105
-
A novel regimen for the treatment of small cell lung cancer SCLC in the elderly| 1991
- 105
-
Lonidamine, chemotherapy (cisplatin and etoposide) and chemotherapy plus lonidamine vs the best supportive care in the treatment of advanced non small cell lung cancer (NSCLC). Preliminary results of a randomized studyGasparini, S. / Farabollini, B. / Isidori, P. / Pinsero, G. / Raspugli, M. / Rossi, A. / Ugolini, M. / Massei, V. et al. | 1991
- 105
-
Chemotherapy for locally advanced (Stage III) non-small cell lung cancerKlastersky, Jean / Nemec, Jaroslav et al. | 1991
- 106
-
Treatment of recurrent small lung cancer after CR with vindesine, ifosfamide and etoposidePawel, J.v. / Faderl, B. / Gatzemeier, U. / Laumen, L. / Schröder, U. et al. | 1991
- 106
-
Phase III studies in the therapy of small cell lung cancer (SCLC): A North Central Cancer Treatment Group (NCCTG) trial| 1991
- 106
-
Treatment of small cell lung cancer (SCLC) in the elderly| 1991
- 106
-
A randomised trial of granulocyte colony stimulating factor (G) in patients with small cell lung cancer (SCLC)| 1991
- 107
-
Phase III trial of cisplatin, vinblastin (VP) vs cisplatin, vinblastin, ifosfamide (VIP) for non-operable non-small lung cancer (NSCLC)| 1991
- 107
-
Randomised trial of oral verapamil with chemotherapy for non-small cell lung cancer (NSCLC)Millward, M.J. / Munro, N. / Cantwell, B.M.J. / Harris, A.L. / Corris, P. et al. | 1991
- 107
-
Treatment of non-small cell lung cancer (NSCLC) with ifosfamide (IF) + 4 epiadriamycin (4 EPI) + platinum (P) vs IF + 4 EPIBrocato, N. / Bruno, M. / Araujo, C. / Temperley, G. / Cervellino, J. / Sparrow, C. / Savulsky, C. / Balbiani, L. et al. | 1991
- 107
-
Cisplatin dose intensity in metastatic non-small cell cell lung cancer: Results of a phase III comparative study| 1991
- 108
-
Potentially synergic effect of combined treatment (chemotherapy+lonidamina+radiotherapy) in inoperable NSCLC| 1991
- 108
-
Ifosfamide, epirubicin and cisplatin (IEP) — Another active combination for small cell lung cancer (SCLC)Thongprasert, Sumitra / Jiemsriponges, Kriengsak / Phothiratana, Chaicharn / Atikachai, Budsaba et al. | 1991
- 108
-
Phase I trial of chloroquinoxaline sulfonamide (CQS): A unique agent with activity in NSCLC selected for study based on activity in an in vitro stem cell assay| 1991
- 108
-
Immunohistochemical detection of CEA and P-glycoprotein (P-gp) in small cell lung cancer (SCLC): With special reference to the tissue expression of CEA and response to chemotherapy| 1991
- 109
-
Phase II study of ifosfamide (IFX), cisplatin (CDDP) and vindesine (VDS) in advanced non-small cell lung cancer (NSCLC)| 1991
- 109
-
High dose combined alkylating agents with autologous bone marrow support (ABMT) followed by consolidative radiotherapy for responding small cell lung cancer (SCLC)| 1991
- 109
-
Iphosphamide(IF) + 4 epidoxorubicin(4EPI) + Vpl6 in the treatment of inoperable small cell lung cancerTemperley, GJ / Balbiani, L / Brocato, N / Sparrow, C / Bruno, M / Savulsky, C / Cervellino, J / Pirisi, C / Araujo, C. et al. | 1991
- 109
-
Quantifying the quality survival time for patients with advanced non-small cell lung cancer (NSCLC) treated with the code regimen| 1991
- 110
-
Phase I study of high dose cisplatin, ifosfamide and VP-16 (VIPP) in advanced non-small cell lung cancer (NSCLC)| 1991
- 110
-
Randomized trial of cisplatin(CDDP) plus ifosfamide(IFM) versus CDDP plus vindesine(VDS) for non small cell lung cancer(NSCLC)| 1991
- 110
-
Phase II trials in small cell lung carcinoma (SCLC) 1970–1990. The case for entering previously treated patients| 1991
- 110
-
Comparison of in vitro cytotoxicity between cisplatin and carboplatin in human non-small cell lung cancer lines| 1991
- 111
-
Randomized study comparing cisplatin(CDDP) and vindesine(VDS) combination(PV) and CDDP, VDS and ifosfamide(IFX) combination(PVI) in non-small cell lung cancer (NSCLC)| 1991
- 111
-
A prospective study of low dose oral etoposide in poor prognosis small cell lung cancer (SCLC)| 1991
- 111
-
Long term survival analysis of stage III & IV non-small cell lung cancer patients (Pts) treated with edatrexate (ETX, 10-Edam)| 1991
- 111
-
Phase II trial of high dose epirubicin and ifosfamide in advanced non small cell lung cancer (NSCLC)| 1991
- 112
-
Pharmacokinetics with a 5 day continuous infusion of a camptothecin derivative, CPT-11| 1991
- 112
-
Correlation between total dose of cisplatin and vibratory perception threshold in chemotherapy-induced neuropathy of lung cancer patientsOshita, Fumihiro / Ohmatsu, Hironobu / Karato, Atsuya / Okamoto, Hiroaki / Kojima, Akira / Ohe, Yuichiro / Tamura, Tomohide / Sasaki, Yasutsuna / Eguchi, Kenji / Shinkai, Tetsu et al. | 1991
- 112
-
A phase II study with continuous infusion cisplatin (CDDP) plus 5-fluorouracil (5-FU) in advanced non-small cell lung cancer (NSCLC)Tsuchiya, S. / Minato, K. / Nakano, H. / Fuekl, N. / Hoshino, H. / Takise, A. / Ezawa, K. / Takel, Y. / Naruse, I. / Nomoto, T. et al. | 1991
- 112
-
Negative phase II study of 5-fluorouracil with high-dose leucovorin in non-small cell lung cancer| 1991
- 113
-
A phase I study of CPT-11 in combination with vindesine and cisplatin in advanced non-small cell lung cancer| 1991
- 113
-
Combined use of BAI and systemic chemotherapy for the treatment of atelectasis in advanced non-small cell lung cancer (NSCLC)| 1991
- 113
-
Experience of angiotensin - and OK-432 - induced hypertension - hyperthermo - immunochemotherapy for lung carcinoma| 1991
- 113
-
New drugs in the treatment of non-small cell lung cancerEttinger, David S. et al. | 1991
- 113
-
Phase II study of whole peptidoglycan (WPG) for malignant pleural effusionImamura, F. / Ikegami, H. / Niitani, H. et al. | 1991
- 114
-
Randomised clinical study of verapamil in addition to chemotherapy in small cell lung cancer (SCLC)| 1991
- 114
-
Malignant atypical carcinoid of the lung: Is chemotherapy the answer?| 1991
- 114
-
Hypotonic cisplatin treatment for carcinomatous pleuritis found at thoracotomy| 1991
- 114
-
Two high-dose epirubicin studies in untreated poorer prognosis small cell lung cancer (SCLC)| 1991
- 115
-
Prospective study of postoperative adjuvant chemotherapy with or without OK-432 for resected non-small cell lung cancer -interim report-| 1991
- 115
-
Phase II study of 120 hour-continuous infusion of cisplatin (P) and etoposide (E) in untreated small cell lung cancer (SCLC)| 1991
- 115
-
Ifosfamide (I), Carboplatin (C) and Etoposide (E) for ‘good prognosis’ small cell lung cancer| 1991
- 115
-
Randomised trial of cyclophosphamide, doxorubicin, vincristine (CAV) versus ifosfamide, etoposide (IE) in small cell lung cancer (SCLC)| 1991
- 116
-
Effect of chemotherapy on colony forming unit-granulocyte macrophage (CFU-GM) in bone marrow and blood of lung cancer patients| 1991
- 116
-
Alternating chemotherapy of cyclophosphamide + adriamycin + vincristine(CAV)--cisplatin + etoposide(PVP) for small cell lung cancer| 1991
- 116
-
Recombinant human granulocyte-macrophage colony stimulating factor significantly reduces the myelosuppression of intensive combination chemotherapy in patients with small cell lung cancer - a randomised double-blind placebo-controlled study| 1991
- 116
-
Phase II trial of etoposide and split-dose cisplatin and pirarubicin (THP) in small cell lung cancer (SCLC)Matsui, Yusaku / Kado, Masao / Izumi, Takateru et al. | 1991
- 117
-
Phase II study of concurrent cisplatin(C), vindesine (V), mitomycin-C(M) chemotherapy plus split course radiotherapy (RT) for inoperable locally advanced non-small cell lung cancer (NSCLC)| 1991
- 117
-
Prospective trial of weekly alternating chemotherapy in extensive small cell lung cancer| 1991
- 117
-
Randomized study on the usefulness of etoposide, UFT, Ubenimex as a postoperative adjuvant chemotherapy for non-small cell lung cancerShimizu, N. / Ando, A. / Teramoto, S. / Ono, K. / Nakajima, Y. / Saeki, H. / Konishi, H. / Higashi, R. / Sugata, H. / Nagao, T. et al. | 1991
- 117
-
A late phase II study of navelbine (vinorelbine), a new vinca alkaloid derivative, in non small cell lung cancerKubota, K. / Furuse, K. / Niitani, H. et al. | 1991
- 118
-
Platino+vindesine(PV) vs PV+lonidamine(L) in non small cell lung cancer(NSCLC). Preliminary results of a randomized studyContu, A. / Olmeo, N. / Ortu, S. / Deriu, A. / Scanu, AC. / Piro, S. / Schintu, G.M. / Bechere, M. / Piras, M. / Pusceddu, G. et al. | 1991
- 118
-
Comparison of chronic oral and intravenous etoposide administration in comdination with cisplatin for the treatment of small cell lung cancer| 1991
- 118
-
Lonidamine combined with cyclofosfamide in treatment of advanced bronchogenic non-small cell carcinoma: Intermediate results of a phase II study in elderly patients| 1991
- 118
-
Chronic daily administration of oral etoposide and cisplatin for advanced non-small cell lung cancer (NSCLC)| 1991
- 119
-
Phase II pilot study of fotemustine - cisplatin combination in 24 patients with advanced non small cell lung carcinomaRiviere, A. / Le Cesne, A / Benoliel, C. / Berille, J. / Le Chevalier, T. et al. | 1991
- 119
-
Augmentation of CDDP cytotoxicity by amphotericin B in CDDP resistant human lung cancer cell lines in vitro and in vivo| 1991
- 119
-
Fotemustine: French multicenter phase II study in 67 patients with advanced non small cell lung carcinoma (NSCLC)Monnier, A. / Pujol, J.L. / Cerinna, M.L. / Riviere, A. / Douillard, J.Y. / Gouva, S. / Benoliel, C. / Berille, J. / Le Cesne, A. / Le Chevalier, T. et al. | 1991
- 119
-
The effect of suramin on human lung cancer cell line in vitroFujiuchi, S. / Tsuji, T. / Onodera, S. / Ishida, S. / Fujikane, T. / Shimizu, T. et al. | 1991
- 120
-
Detection and characterization of nuclear proteins that recognize cisplatin-damaged DNA in human lung cancer cell lines| 1991
- 120
-
Mechanism of cisplatin(CDDP) and platinum derivatives resistance in non-small cell lung cancer cell line(PC-14/CDDP) and its circumvention by tetrachloro (D,L-trans) 1,2-diaminocyclohexaneplatinum(IV) (tetraplatin)| 1991
- 120
-
Increased phosphorylation of nuclear phosphoproteins in human lung cancer cells resistant to cisplatin| 1991
- 120
-
Prospective analysis of prediction from creatine clearance (Ccr.) of thrombocytopenia in patients with (glycolato-O,O′)-diammine platinum (II) (254-S), a new platinum complex, in clinical phase II study| 1991
- 121
-
Etoposide and teniposide in untreated small cell lung cancer (SCLC)| 1991
- 121
-
A three-armed randomized trial in small cell lung cancer (SCLC) of two induction regimens with teniposide and cisplatin or carboplatin followed by alternating chemotherapy versus alternating chemotherapy| 1991
- 121
-
Combination chemotherapy with cisplatin, ifosfamide and etoposide for small cell lung cancer| 1991
- 121
-
Phase II study of gemcitabine in non small cell lung cancer (NSCLC)| 1991
- 122
-
Fractionated high doses (HD) of epirubicin (E) in adenocarcinoma of the lung (ADL)Villar, A. / Antón, E. / Jimeno, J. / Aranda, E. / Balaña, C. / Massuti, B. / Lizón, J. / Carrato, A. / Belón, J. / Candel, MT. et al. | 1991
- 122
-
Results of postoperative intrathoracic chemothermotherapy (PICT) for locally advanced lung cancer with carcinomatous pleuritis| 1991
- 122
-
In vivo activity and pharmacokinetic analysis by 19F-magnetic resonance spectroscopy (FMRS) of 2′2′difluorodeoxycyticine (DFDC, gemcitabine) in small cell lung cancer (SCLC) xenograftsKristjansen, PEG / Quistorff, B / Spang-Thomsen, M / Hansen, HH et al. | 1991
- 122
-
A randomized comparative study of 254-S/vindesine (VDS) vs. cisplatin (CDDP)/VDS for advanced non-small cell lung cancer (NSCLC)| 1991
- 123
-
Dose intensive weekly code chemotherapy (CT) with or without recombinant human granulocyte colony-stimulating factor (rhG-CSF) in extensive-stage (ES) small cell lung cancer (SCLC)| 1991
- 123
-
CPT-11, a new derivative of camptothecin, for patients with previously treated small cell lung cancer (SCLC)| 1991
- 123
-
Biologicals in the therapy of lung cancerStahel, Rolf A. et al. | 1991
- 123
-
Double masking study of Ubenimex (bestatin) on squamous cell lung cancerNakagawa, Kazuhiko / Fukuoka, Masahiro / Genka, Keiichiro / Sakuma, Akira / Niitani, Hisanobu et al. | 1991
- 124
-
Synergistic effects of CPT-11 and cisplatin or etoposide on human lung cancer cell lines demonstrated by computer analysis| 1991
- 124
-
Alternative 6 drug combination chemotherapy consisted of (A): cisplatinum(CDDP)+etoposide(EP)+ vincristine(VCR) and (B): cyclophosphamide(CPM)+ adriamycin(ADM)+methotrexate(MTX) in small cell lung cancer(SCLC)Saito, J. / Koinumaru, S. / Tsukamoto, T. / Nakai, Y. et al. | 1991
- 124
-
Chemotherapy versus chemo-BRM therapy in adenocarcinoma of the lung: In relation to quality of lifeNakai, Y. / Koinumaru, S. / Saito, J. / Fukuoka, M. / Kobayashi, K. / Gemma, A. / Niitani, H. / Ogawa, N. / Kimura, K. / Nishiwaki, Y. et al. | 1991
- 124
-
Assessment of postoperative adjuvant chemotherapy on non-small cell lung cancer| 1991
- 125
-
Phase II study of CPT-11, new camptothecin derivative, in previously untreated non-small cell lung cancer (NSCLC)| 1991
- 125
-
Cisplatin, etoposide and mitomycin (CVM) or adriamycin (CVA) in non-small cell lung cancer. (NSCLC)| 1991
- 125
-
Phase II study of zeniplatin, an active new agent in advanced non-small cell lung cancer (NSCLC)| 1991
- 125
-
Preliminary report of a randomized multi-center controlled study of immuno-chemotherapy versus chemotherapy in small cell lung cancerHayasaka, S. / Yoshinaga, K. / Kinuwaki, E. / Fukuoka, M. / Furuse, K. / Kawahara, M. / Kubota, K. / Ogawa, N. / Nishikawa, H. / Uchiyama, T. et al. | 1991
- 126
-
Etoposide and high dose carboplatin in previously untreated patients with small cell lung cancer (SCLC)| 1991
- 126
-
Role of leucovorin (LV) for edatrexate (E), cyclophosphamide (C) and cisplatin (P) regimen| 1991
- 126
-
A randomised trial comparing a low toxicity regimen (carboplatin, vinblastine & methotrexate (CVM) against adriamycin, cyclophosphamide & etoposide in small cell lung cancer (SCLC)| 1991
- 126
-
Augmentation of cytotoxicity of chemotherapy by cytokines in non small cell lung cancer. A randomized phase II study| 1991
- 127
-
Dose intensity (DI) of the CAVE regimen in SCLC is important for achieving a higher response rate (R)Sirzea, F. / Lewensohn, R. / Westerberg, R. et al. | 1991
- 127
-
Natural alpha interferon as maintenance therapy for small cell lung cancerMattson, K / Niiranen, A / Holsti, LR / Holsti, P / Pyrhönen, S / Kumpulainen, E / Numminen, S / Cantell, K et al. | 1991
- 127
-
Extended administration of oral cyclophosphamide (C) and oral etoposide (E) for the treatment of stage IV non-small cell lung cancer - A southwest oncology group study| 1991
- 128
-
Pilot study of multi-cyclic combination chemotherapy (MCCCT) for extensive small cell lung cancer (SCLC)Kobayashi, Kunihiko / Kurane, Shuuji / Morikawa, Tetsuyuki / Nukariya, Naotaka / Hino, Mitsunori / Niitani, Hisanobu et al. | 1991
- 128
-
MIC chemotherapy in NSCLC - Not a palliative regimenHarnett, P. / Taper, J. / Gurney, H. / Flynn, P. / Stuart-Harris, R. et al. | 1991
- 128
-
Teniposide for brain metastases of small cell lung cancer, EORTC protocol 08873| 1991